• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ARK Genomic Revolution ETF (NY:ARKG)

51.30 +2.01 (+4.08%)
Official Closing Price Updated: 8:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,802,540
Open 49.76
Bid (Size) 51.25 (5,900)
Ask (Size) 51.50 (100)
Prev. Close 49.29
Today's Range 49.62 - 52.08
52wk Range 24.60 - 58.83
Shares Outstanding 418,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cathie Wood's Ark Has Delivered Just a 13.8% Annualized Return Since 2014, Roughly Matching the S&P 500. Should You Trust Her Bold Predictions for 2030? ↗
September 06, 2026
Are her big ideas turning into big returns? 
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
August 31, 2026
Ark Invest was a buyer of tech stocks down as much as 53% from their recent all-time highs. 
Via The Motley Fool
Topics ETFs

Performance

52-Week Range 12.8% below 52-week high
51.30
24.6052W Low 58.8352W High
1 Week 12.8% below 1-week high
48.291W Low 58.831W High

ARK Genomic Revolution ETF (ARKG) traded between $24.60 and $58.83 over the past 52 weeks and last traded at $51.30, 12.8% below its 52-week high. Over the past week it ranged between $48.29 and $58.83.

Past 12 Months
-9.6%
+13.0%
+26.4%
+83.9%
+75.8%
+69.0%
1W -$5.47
1M +$5.92
3M +$10.71
6M +$23.40
YTD +$22.12
1Y +$20.95

ARKG was +69.0% over the past year, +83.9% over six months, +75.8% year to date, -9.6% in the last week.

12 Months vs Market
ARKG
+69.0%
DIA
+13.5%
SPY
+19.2%
QQQ
+27.4%
IWM
+17.3%

Over the past 12 months ARKG returned +69.0% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.

Volume & Liquidity 1.50× 3-mo avg
Today 5,802,540 3-mo avg 3.9M
1W
7.7M
1M
5.1M
3M
3.9M
6M
3.6M
YTD
3.3M
1Y
3.4M

ARKG most recently traded 5,802,540 shares against a 3-month average daily volume of 3.9M.

More News

Read More
News headline image
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. ↗
July 29, 2026
Via The Motley Fool
Topics ETFs Government
BEAM Stock In Focus As FDA Alignment Wins William Blair’s Praise ↗
January 12, 2026
Via Stocktwits
News headline image
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating ↗
July 22, 2026
Via The Motley Fool
Topics ETFs
News headline image
Cathie Wood Just Bet Big on This Biotech Stock ↗
July 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
Cathie Wood's Ark Invest Sold $7.4 Million of BioNTech Stock ↗
July 14, 2026
Via The Motley Fool
Topics ETFs
News headline image
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy? ↗
July 14, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Why Is CRSP Stock Falling Pre-Market Today? ↗
March 10, 2026
Via Stocktwits
News headline image
RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
February 25, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
February 17, 2026
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
February 17, 2026
Via Stocktwits
News headline image
TWST Shares Rise 8% — What’s Driving The Rally? ↗
February 02, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
January 16, 2026
Via Stocktwits
Topics Artificial Intelligence ETFs
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
November 30, 2025
Via The Motley Fool
Topics ETFs
News headline image
Why Tempus AI Stock Soared This Week ↗
November 28, 2025
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
November 03, 2025
Via Benzinga
Topics ETFs
News headline image
Wellgistics Health's 200% Surge Puts AI-Pharma Tie-Ups On The ETF Map ↗
October 24, 2025
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Wellgistics And DataVault Team Up To Transform Prescription Tracking ↗
October 22, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗
October 17, 2025
Via Benzinga
Topics ETFs Government
News headline image
Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any? ↗
October 10, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200% ↗
October 08, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
Via Benzinga
Topics ETFs
News headline image
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI ↗
September 16, 2025
Via Benzinga
News headline image
Cathie Wood, Dan Ives Align On These 11 AI Stock Picks — Some Might Surprise You ↗
September 15, 2025
Via Benzinga
Topics Artificial Intelligence ETFs

Frequently Asked Questions

Is ARK Genomic Revolution ETF publicly traded?
Yes, ARK Genomic Revolution ETF is publicly traded.
What exchange does ARK Genomic Revolution ETF trade on?
ARK Genomic Revolution ETF trades on the New York Stock Exchange
What is the ticker symbol for ARK Genomic Revolution ETF?
The ticker symbol for ARK Genomic Revolution ETF is ARKG on the New York Stock Exchange
What is the current price of ARK Genomic Revolution ETF?
The current price of ARK Genomic Revolution ETF is 51.30
When was ARK Genomic Revolution ETF last traded?
The last trade of ARK Genomic Revolution ETF was at 10/09/26 08:00 PM ET
What is the market capitalization of ARK Genomic Revolution ETF?
The market capitalization of ARK Genomic Revolution ETF is 21.44M
How many shares of ARK Genomic Revolution ETF are outstanding?
ARK Genomic Revolution ETF has 21M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap